About
Dr. Garrett Vygantas is the Founding Managing Partner at Riverine Ventures, a early stage Life Science and Healthcare focused Venture Capital firm. Previously he was a Managing Director at OSF Healthcare Ventures and served on the Investment Committee. Prior to Riverine, Garrett was Chief Business Officer at Corsair Pharma, a biotech company developing innovative therapeutics to treat Pulmonary Hypertension. As an entrepreneur, Garrett co-founded TherOptix, an ocular therapeutics company and Mitre Medical, a structural heart disease medtech. He was a Partner at Jump Capital where he led the firm's healthcare investments. Prior to Jump, Garrett founded NewBridge Pharmaceuticals and served as President & CEO as EIR on the Burrill & Co Venture Capital Group. Earlier in his career, Garrett helped launch Lucentis, a breakthrough therapy for wet age related macular degeneration developed by Genentech, member of the Roche Group. Garrett previously worked with the Health Care Investment Ban
Position in the VCSift Database
- • 180 investors hold the Co-founder & Managing Partner role in VCSift. Garrett Vygantas is one of them.
- • 7,285 investors are based in San Francisco, California, United States.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Location
- San Francisco, US
Contact Information
Find more investors like Garrett
Search Investors